Back to trial details

Intake questionnaire

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

Applying to University of Nebraska Medical Center · Omaha, Nebraska

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Small Cell Lung Cancer (SCLC)?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Omaha for study visits?